The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Galectin-1: A Link Between Tumor Hypoxia and Tumor Immune Privilege
Open accessAbstract
Purpose: To identify a 15-KDa novel hypoxia-induced secreted protein in head and neck squamous cell carcinomas (HNSCC) and to determine its role in malignant progression. Methods: We used surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS) and tandem MS to identify a novel hypoxia-induced secreted protein in FaDu cells. We used immunoblots, real-time polymerase chain reaction (PCR), and enzyme-linked immunoabsorbent assay to confirm the hypoxic induction of this secreted protein as galectin-1 in cell lines and xenografts. We stained tumor tissues from 101 HNSCC patients for galectin-1, CA IX (carbonic anhydrase IX, a hypoxia marker) and CD3 (a T-cell marker). Expression of these markers was correlated to each other and to treatment outcomes. Results: SELDI-TOF studies yielded a hypoxia-induced peak at 15 kDa that proved to be galectin-1 by MS analysis. Immunoblots and PCR studies confirmed increased galectin-1 expression by hypoxia in several cancer cell lines. Plasma levels of galectin-1 were higher in tumor-bearing severe combined immunodeficiency (SCID) mice breathing 10% O 2 compared with mice breathing room air. In HNSCC patients, there was a significant correlation between galectin-1 and CA IX staining (P = .01) and a strong inverse correlation between galectin-1 and CD3 staining (P = .01). Expression of galectin-1 and CD3 were significant predictors for overall survival on multivariate analysis. Conclusion: Galectin-1 is a novel hypoxia-regulated protein and a prognostic marker in HNSCC. This study presents a new mechanism on how hypoxia can affect the malignant progression and therapeutic response of solid tumors by regulating the secretion of proteins that modulate immune privilege.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Galectins as modulators of tumour progression
Liu, F.-T., & Rabinovich, G. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1527 · Cited by 1,439
Apoptosis of T cells mediated by galectin-1
Perillo, N. L., Pace, K. E., Seilhamer, J. J., & Baum, L. G. (1995) · Nature · doi:10.1038/378736a0 · Cited by 1,074
Secretion of the galectin family of mammalian carbohydrate-binding proteins
Hughes, R. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00177-4 · Cited by 636
XBP1 Is Essential for Survival under Hypoxic Conditions and Is Required for Tumor Growth
Romero-Ramirez, L., Cao, H., Nelson, D., Hammond, E., Lee, A.-H., Yoshida, H., Mori, K., Glimcher, L. H., Denko, N. C., Giaccia, A. J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1606 · Cited by 570
Self-citationOxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome
Brizel, D. M., Dodge, R. K., Clough, R. W., & Dewhirst, M. W. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00102-4 · Cited by 548
Rubinstein, N., Alvarez, M., Zwirner, N. W., Toscano, M. A., Ilarregui, J. M., Bravo, A., Mordoh, J., Fainboim, L., Podhajcer, O. L., & Rabinovich, G. A. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00024-8 · Cited by 531
Transcriptional Response to Hypoxia in Human Tumors
Lal, A., Peters, H., St. Croix, B., Haroon, Z. A., Dewhirst, M. W., Strausberg, R. L., Kaanders, J. H. A. M., van der Kogel, A. J., & Riggins, G. J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.17.1337 · Cited by 320
Swinson, D. E. B., Jones, J. L., Richardson, D., Wykoff, C., Turley, H., Pastorek, J., Taub, N., Harris, A. L., & O’Byrne, K. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.132 · Cited by 287
Self-citationKopitz, J., von Reitzenstein, C., André, S., Kaltner, H., Uhl, J., Ehemann, V., Cantz, M., & Gabius, H.-J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105135200 · Cited by 281
Nordsmark, M., & Overgaard, J. (2000) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(00)00223-1 · Cited by 281
Bystander elimination of antigen loss variants in established tumors
Spiotto, M. T., Rowley, D. A., & Schreiber, H. (2004) · Nature Medicine · doi:10.1038/nm999 · Cited by 260
TNM classification of malignant tumors. A comparison between the new (1987) and the old editions
Sobin, L. H., Hermanek, P., & Hutter, R. V. P. (1988) · Cancer · Cited by 222
RABINOVICH, ARIEL, HERSHKOVIZ, HIRABAYASHI, KASAI, & LIDER (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00746.x · Cited by 220
Galectins in cell growth and apoptosis
Yang, R.-Y., & Liu, F.-T. (2003) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s000180300022 · Cited by 208
Chung, C. D., Patel, V. P., Moran, M., Lewis, L. A., & Miceli, M. C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3722 · Cited by 205
Liu, C. L., Prapong, W., Natkunam, Y., Alizadeh, A., Montgomery, K., Gilks, C. B., & van de Rijn, M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64434-3 · Cited by 199
Galectins: A New Family of Regulators of Inflammation
Liu, F.-T. (2000) · Clinical Immunology · doi:10.1006/clim.2000.4912 · Cited by 197
Camby, I., Belot, N., Rorive, S., Lefranc, F., Maurage, C., Lahm, H., Kaltner, H., Hadari, Y., Ruchoux, M., Brotchi, J., et al. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00377.x · Cited by 172
Identification of tumor‐associated proteins in oral tongue squamous cell carcinoma by proteomics
He, Q., Chen, J., Kung, H., et al. (2004) · PROTEOMICS · doi:10.1002/pmic.200300550 · Cited by 149
Baum, L. G., Seilhamer, J. J., Pang, M., Levine, W. B., Beynon, D., & Berliner, J. A. (1995) · Glycoconjugate Journal · doi:10.1007/bf00731870 · Cited by 118
Glycoprotein 90K/MAC‐2BP interacts with galectin‐1 and mediates galectin‐1–induced cell aggregation
Tinari, N., Kuwabara, I., Huflejt, M. E., Shen, P. F., Iacobelli, S., & Liu, F. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(200002)9999:9999<::aid-ijc1022>3.3.co;2-q · Cited by 99
Clausse, N., van den Brûle, F., Waltregny, D., Garnier, F., & Castronovo, V. (1999) · Angiogenesis · doi:10.1023/a:1026584523789 · Cited by 93
Pomerantz, R. G., & Grandis, J. R. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.09.015 · Cited by 81
Soltys, S. G., Le, Q., Shi, G., Tibshirani, R. J., Giaccia, A. J., & Koong, A. C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0469 · Cited by 75
Self-citation(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Short-term versus long-term antimicrobial prophylaxis in oncologic head and neck surgery
Righi, M., Manfredi, R., Farneti, G., Pasquini, E., & Cenacchi, V. (1996) · Head & Neck · doi:10.1002/(sici)1097-0347(199609/10)18:5 · Cited by 60
Oxygen Tension Measurements of Head and Neck Cancers
Terris, D. J., & Dunphy, E. P. (1994) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1994.01880270031006 · Cited by 53
Oxygen tension measurements of tumors growing in mice
Adam, M., Dorie, M. J., & Brown, J. M. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00157-1 · Cited by 53
Chen, Y., Shi, G., Xia, W., Kong, C. S., Zhao, S., Gaw, A. F., Chen, E. Y., Yang, G. P., Giaccia, A. J., Le, Q., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0899 · Cited by 40
Self-citationp16 inactivation in small-sized lung adenocarcinoma: Its association with poor prognosis
Kawabuchi, B., Moriyama, S., Hironaka, M., Fujii, T., Koike, M., Moriyama, H., Nishimura, Y., Mizuno, S., & Fukayama, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990219)84:1<39::aid-ijc8>3.0.co;2-e · Cited by 39
Nelson, D. W., Cao, H., Zhu, Y., Sunar‐Reeder, B., Choi, C. Y. H., Faix, J. D., Brown, J. M., Koong, A. C., Giaccia, A. J., & Le, Q. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2602 · Cited by 11
Self-citationTumor Deprivation of Oxygen and Tumor Suppressor Gene Function
Yun, Z., & Giaccia, A. J. (2003) · Humana Press eBooks · doi:10.1385/1-59259-329-1:485 · Cited by 7
Self-citation
Cited by
Immunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,702
The hypoxic tumour microenvironment
Petrova, V., Annicchiarico-Petruzzelli, M., Melino, G., & Amelio, I. (2018) · Oncogenesis · doi:10.1038/s41389-017-0011-9 · Cited by 1,019
Turning 'sweet' on immunity: galectin–glycan interactions in immune tolerance and inflammation
Rabinovich, G. A., & Toscano, M. A. (2009) · Nature Reviews Immunology · doi:10.1038/nri2536 · Cited by 904
Galectin-1: a small protein with major functions
Camby, I., Le Mercier, M., Lefranc, F., & Kiss, R. (2006) · Glycobiology · doi:10.1093/glycob/cwl025 · Cited by 893
Emami Nejad, A., Najafgholian, S., Rostami, A., Sistani, A., Shojaeifar, S., Esparvarinha, M., Nedaeinia, R., Haghjooy Javanmard, S., Taherian, M., Ahmadlou, M., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-020-01719-5 · Cited by 693
Metadata
- Authors
- Le, Q.-T., Shi, G., Cao, H., Nelson, D. W., Wang, Y., Chen, E. Y., Zhao, S., Kong, C., Richardson, D., O'Byrne, K. J., Giaccia, A. J., & Koong, A. C.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-12-10
- Volume
- 23
- Issue
- 35
- Pages
- 8932-8941
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1538326806
- Cited by
- 258
- References
- 33
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.